Pharma heavyweights just stepped in 👀

Tiny biotech is attracting Wall Street and industry firepower...

February 23, 2026

Hey Folks, Jeff Bishop here (Bullseye Members, look out for my email at 10AM EST) -

My first “tactical trade” alert of 2026 jumped 15% the same day… and shortly after, it ripped 54%.

Now it has pulled back, and I think most investors are missing what’s happening just under the surface.

This small-cap biotech just brought in the former head of global ophthalmology behind two blockbuster drugs… plus a medical chief who helped launch a billion-dollar orphan therapy.

At the same time, Stephen Cohen’s hedge fund (Point 72), disclosed a multi-million share position in this tiny stock.  

Keep in mind that this is one of the largest and best-performing hedge funds in the world.

Why do you think they would make a strategic investment in a tiny biotech stock that hardly anyone knows about?

Maybe because they know that by doing their homework and taking risks when the rest of the world is ignoring an opportunity is the best way to make money.

On top of that, a major investment bank initiated coverage with a triple-digit upside target.

It’s no surprise that insiders have been buying aggressively for months.

Meanwhile, the company’s lead drug has delivered strong Phase 2 results in a massive dry eye market, and may be targeting an even bigger unmet need with no approved treatments today.

The stock recently stabilized after a sharp pullback, and I’m watching closely to see if buyers step back in.

If you want the full breakdown — including why this could be setting up for another run — click below and see what I’m seeing.

I think we will have a very exciting day in front of us.  You should check this stock out as soon as you can and start watching it.

I also invite you to join me live at 11am EST in our Market Masters live trading room, where I will discuss many other top ideas this week.

In fact, bookmark this link:  https://app.ragingbull.com/room/market-masters

That link is your ticket to free access to our trading room any time during the day.

No credit cards, downloads, or gimmicks.  

Just a great place to talk stocks and find new ideas – and maybe a few friends along the way as well!

To Your Success,

DISCLAIMER: This entity is owned by Sherwood Ventures LLC (SV). Full disclaimer https://bullseyealerts.com/disclaimer/. We are a financial publisher, not a registered investment advisor. Our content is for informational purposes only and should not be considered personalized investment advice. All trading involves substantial risk of loss and you may lose some or all of your invested capital. Past performance does not guarantee future results.

*PAID PROMOTION: The content above is a paid promotion. Sherwood Ventures receives compensation from the company or affiliate partners featured in this email. We are paid to distribute this content and have a financial interest in promoting these products or services. Sherwood Ventures is not responsible for any content hosted on third-party sites or your experience with third-party advertisers. It is the third party's responsibility to ensure compliance with applicable laws. We may hold positions in securities we discuss and may trade without notice. We make no guarantees or warranties about what is advertised and have no fiduciary duty to subscribers. Always consult a qualified financial professional before making investment decisions.